Focusing on MyD88-mutant cases in DC-stratified DLBCL patients68, we found the DChigh/MyD88mut subgroup to experience a significantly better survival than the DClow/MyD88mut subgroup (Fig. 6d). The gene discussed is MYD88; the disease is diffuse large B-cell lymphoma.